Artículo de revista
Light-induced release of the cardioprotective peptide angiotensin-(1-9) from thermosensitive liposomes with gold nanoclusters
Fecha
2020Registro en:
Journal of Controlled Release 328 (2020) 859–872
10.1016/j.jconrel.2020.11.002
Autor
Bejarano, Julián
Rojas, Aldo
Ramírez Sagredo, Andrea
Riveros Salvatierra, Ana
Morales Zavala, Francisco
Flores, Yvo
Riquelme Meléndez, Jaime
Guzmán, Fanny
Araya, Eyleen
Chiong Lay, Mario
Ocaranza, María Paz
Morales Montecinos, Javier
Villamizar Sarmiento, María Gabriela
Sánchez Vergara, Gina
Lavandero González, Sergio
Kogan, Marcelo J.
Institución
Resumen
Angiotensin-(1-9), a component of the non-canonical renin-angiotensin system, has a short half-life in blood. This peptide has shown to prevent and/or attenuate hypertension and cardiovascular remodeling. A controlled release of angiotensin-(1-9) is needed for its delivery to the heart. Our aim was to develop a drug delivery system for angiotensin-(1-9). Thermosensitive liposomes (LipoTherm) were prepared with gold nanoclusters (LipoThermAuNC) to increase the stability and reach a temporal and spatial control of angiotensin-(1-9) release. Encapsulation efficiencies of nearly 50% were achieved in LipoTherm, reaching a total angiotensin-(1-9) loading of around 180 mu M. This angiotensin-(1-9)-loaded LipoTherm sized around 100 nm and exhibited a phase transition temperature of 43.C. AuNC were grown on LipoTherm and the new hybrid nanosystem showed energy absorption in the near-infrared (NIR) wavelength range. By NIR laser irradiation, a controlled release of angiotensin-(1-9) was achieved from the LipoTherm-AuNC nanosystem. These nanosystems did not show any cytotoxic effect on cultured cardiomyocytes. Biological activity of angiotensin-(1-9) released from the LipoTherm-AuNCbased nanosystem was confirmed using an ex vivo Langendorff heart model.